Option Care Health Inc

OPCH is carving out an early Stage 1 consolidation with a clear higher-highs & higher-lows structure supported by rising short-term EMAs. The medium-term bias is bullish, as pattern asymmetry and minor pullback support at the 9/21 EMA cluster favor continuation. Short-term conditions remain constructive with price tightly tracking above EMAs, justifying a buy-on-pullback stance into this support zone. However, the longer-term trend remains bearish, and a breach below the EMA cluster would invalidate the bullish posture.

• ↑Q1 2026 revenue $1.4B (+1% YoY); full-year guidance $5.675–$5.775B intact.
• ↑Acute therapies achieve high single-digit growth, backed by tech and process investments.
• ↓A $55M headwind in the CID portfolio dragged Q1 revenue growth by ~600bps.